Trial Profile
HALT Progression of Polycystic Kidney Disease Study B
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Lisinopril (Primary) ; Telmisartan (Primary)
- Indications Polycystic kidney disease
- Focus Therapeutic Use
- Acronyms HALT PKD B
- 12 Mar 2015 New trial record